Key Points
- Transseptal access has been widely disseminated with a relatively low complication rate.
- The VersaCross Transseptal system utilizes radiofrequency energy to facilitate transseptal access enhancing ease and efficiency of procedures.
- Rising costs of structural heart interventions may impact resource allocation for medical devices.
CONFLICT OF INTEREST
Marvin H. Eng is a clinical proctor for Edwards Lifesciences and Medtronic.
REFERENCES
- 1Chhatriwalla AK, Vemulapalli S, Holmes DR, et al. Institutional experience with transcatheter mitral valve repair and clinical outcomes: insights from the TVT registry. JACC Cardiovasc Interv. 2019; 12(14): 1342-1352.
- 2Freeman JV, Varosy P, Price MJ, et al. The NCDR left atrial appendage occlusion registry. J Am Coll Cardiol. 2020; 75(13): 1503-1518.
- 3Sayah N, Simon F, Garceau P, et al. Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair. Catheter Cardiovasc Interv. 2021; 97: 1230-1234.
- 4Khan JM, Rogers T, Eng MH, Lederman RJ, Greenbaum AB. Guidewire electrosurgery-assisted trans-septal puncture. Catheter Cardiovasc Interv. 2018; 91(6): 1164-1170.
- 5Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA. Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation. J Interv Card Electrophysiol. 2013; 36(2): 157-165.
